 Connection
David Simpson to Neuromuscular Agents
This is a "connection" page, showing publications David Simpson has written about Neuromuscular Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
5.399 |
|
|
|
-
Wissel J, Cam?es-Barbosa A, Comes G, Althaus M, Scheschonka A, Simpson DM. Pain Reduction in Adults with Limb Spasticity Following Treatment with IncobotulinumtoxinA: A Pooled Analysis. Toxins (Basel). 2021 Dec 11; 13(12).
Score: 0.757
-
Jog M, Lee J, Scheschonka A, Chen R, Ismail F, Boulias C, Hobson D, King D, Althaus M, Simon O, Dersch H, Frucht S, Simpson DM. Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study. Toxins (Basel). 2020 Dec 20; 12(12).
Score: 0.707
-
Bensmail D, Wissel J, Laffont I, Simon O, Scheschonka A, Flatau-Baqu? B, Dressler D, Simpson DM. Efficacy of incobotulinumtoxinA for the treatment of adult lower-limb post-stroke spasticity, including pes equinovarus. Ann Phys Rehabil Med. 2021 Mar; 64(2):101376.
Score: 0.674
-
Wissel J, Bensmail D, Scheschonka A, Flatau-Baqu? B, Simon O, Althaus M, Simpson DM. Post hoc analysis of the improvement in shoulder spasticity and safety observed following treatment with incobotulinumtoxinA. J Rehabil Med. 2020 Mar 18; 52(3):jrm00028.
Score: 0.671
-
Fheodoroff K, Rekand T, Medeiros L, Ko?mehl P, Wissel J, Bensmail D, Scheschonka A, Flatau-Baqu? B, Simon O, Dressler D, Simpson DM. Quality of life in subjects with upper- and lower-limb spasticity treated with incobotulinumtoxinA. Health Qual Life Outcomes. 2020 Mar 04; 18(1):51.
Score: 0.669
-
Zakin E, Simpson D. Evidence on botulinum toxin in selected disorders. Toxicon. 2018 Jun 01; 147:134-140.
Score: 0.579
-
Thomas AM, Simpson DM. Contralateral weakness following botulinum toxin for poststroke spasticity. Muscle Nerve. 2012 Sep; 46(3):443-8.
Score: 0.398
-
Simpson DM, Gracies JM, Graham K, Hallett M, Miyasaki J, Naumann M, Russman B, Simpson L, So Y. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Neurology. 2009 Sep 01; 73(9):736-7; author reply 737-8.
Score: 0.323
-
Simpson DM, Gracies JM, Yablon SA, Barbano R, Brashear A. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study. J Neurol Neurosurg Psychiatry. 2009 Apr; 80(4):380-5.
Score: 0.305
-
Wissel J, Bensmail D, Ferreira JJ, Molteni F, Satkunam L, Moraleda S, Rekand T, McGuire J, Scheschonka A, Flatau-Baqu? B, Simon O, Rochford ET, Dressler D, Simpson DM. Safety and efficacy of incobotulinumtoxinA doses up to 800 U in limb spasticity: The TOWER study. Neurology. 2017 Apr 04; 88(14):1321-1328.
Score: 0.136
-
Vinti M, Costantino F, Bayle N, Simpson DM, Weisz DJ, Gracies JM. Spastic cocontraction in hemiparesis: effects of botulinum toxin. Muscle Nerve. 2012 Dec; 46(6):926-31.
Score: 0.100
-
Dobkin BH, Landau WM, Sahrmann S, Thomas Thach W, Simpson DM, Gracies JM, Graham K, Hallett M, Miyasaki J, Naumann M, Russman B, Simpson L, So Y. Assessment: botulinum neurotoxin for the treatment of spasticity (an evidence-based review). Neurology. 2009 Sep 01; 73(9):736; author reply 737-8.
Score: 0.081
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|